White label ELPA - ClinicalTrials.eu

Study of Chemotherapy and Nivolumab for Patients with Locally Advanced Non-Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Study Comparing Subcutaneous and Intravenous Ocrelizumab for Patients with Multiple Sclerosis

Not recruiting

3 1 1 1
Investigated diseases:
- Multiple sclerosis
Study of LN-144 and LN-145 (Tumor Infiltrating Lymphocytes) in patients with solid tumors, including melanoma, head and neck cancer, and non-small cell lung cancer

Not recruiting

2 1 1 1
Investigated diseases:
Study of Afamitresgene Autoleucel for Patients with Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

Not recruiting

2 1 1
Investigated diseases:
Study on Reducing Peripheral Edema in Patients Switching from Amlodipine Besilate to Levamlodipine Succinate

Not recruiting

2 1 1
Investigated diseases:
- Oedema
Study Comparing bb2121 with Standard Treatments for Patients with Relapsed and Refractory Multiple Myeloma

Not recruiting

3 1 1 1
Investigated diseases:
- Plasma cell myeloma
- Plasma cell myeloma refractory
+1
Study of Immunotherapy Combinations with GSK4428859, Dostarlimab, and GSK6097608 for Patients with Advanced Non-Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
+5
Study on the Effects of Somapacitan and Somatropin in Children with Growth Hormone Deficiency

Not recruiting

3 1 1 1
Investigated diseases:
- Growth hormone deficiency
+2
Study on Leflunomide and Hydroxychloroquine for Patients with Primary Sjögren’s Syndrome

Not recruiting

2 1 1
Investigated diseases:
- Sjogren’s syndrome
Study of PF-07220060 and PF-07104091 with Endocrine Therapy for Patients with Advanced HR-positive HER2-negative Breast Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Breast cancer
- Breast cancer metastatic

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies